Free Trial

Exelon (EXC) Stock Forecast & Price Target

Exelon logo
$39.49 +0.36 (+0.92%)
(As of 11/26/2024 06:03 PM ET)

Exelon - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
10
Buy
4

Based on 14 Wall Street analysts who have issued ratings for Exelon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 14 analysts, 10 have given a hold rating, and 4 have given a buy rating for EXC.

Consensus Price Target

$41.25
4.46% Upside
According to the 14 analysts' twelve-month price targets for Exelon, the average price target is $41.25. The highest price target for EXC is $46.00, while the lowest price target for EXC is $36.00. The average price target represents a forecasted upside of 4.46% from the current price of $39.49.
Get the Latest News and Ratings for EXC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Exelon and its competitors.

Sign Up

EXC Analyst Ratings Over Time

TypeCurrent Forecast
11/28/23 to 11/27/24
1 Month Ago
10/29/23 to 10/28/24
3 Months Ago
8/30/23 to 8/29/24
1 Year Ago
11/28/22 to 11/28/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
10 Hold rating(s)
10 Hold rating(s)
10 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$41.25$41.33$39.82$43.00
Forecasted Upside4.46% Upside2.74% Upside4.70% Upside9.81% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy

EXC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EXC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Exelon Stock vs. The Competition

TypeExelonUtilities CompaniesS&P 500
Consensus Rating Score
2.29
2.50
2.50
Consensus RatingHoldHoldModerate Buy
Predicted Upside4.46% Upside21.75% Upside6.71% Upside
News Sentiment Rating
Positive News

See Recent EXC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/22/2024Morgan Stanley
3 of 5 stars
 Lower TargetEqual Weight ➝ Equal Weight$46.00 ➝ $44.00+12.68%
10/15/2024Barclays
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$41.00 ➝ $44.00+8.37%
9/20/2024UBS Group
4 of 5 stars
 Boost TargetNeutral ➝ Neutral$40.00 ➝ $43.00+7.82%
9/19/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$46.00+17.08%
8/20/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$37.00 ➝ $40.00+6.30%
8/2/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$40.00 ➝ $42.00+9.12%
5/3/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$40.00 ➝ $42.00+12.21%
1/19/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$38.00 ➝ $36.00+2.53%
1/10/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$36.00 ➝ $39.00+7.03%
1/8/2024Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Storozynski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
12/19/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Perform ➝ Sector Perform$45.00 ➝ $38.00+9.16%
12/18/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$41.00+18.09%
12/15/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ In-Line
12/15/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$44.00 ➝ $40.00+5.54%
6/7/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell$39.00-3.32%
1/23/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$42.00 ➝ $46.00+10.00%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:42 AM ET.


Should I Buy Exelon Stock? EXC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, November 25, 2024. Please send any questions or comments about these Exelon pros and cons to contact@marketbeat.com.

Exelon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Exelon Co.:

  • Exelon Co. recently reported earnings per share (EPS) of $0.71, exceeding analysts' expectations of $0.67, indicating strong financial performance and effective management.
  • The company has a solid market capitalization of approximately $39 billion, which reflects its stability and potential for growth in the utility sector.
  • Exelon Co. has a current stock price of $38.71, which is below the average price target of $41.25 set by analysts, suggesting potential for price appreciation.
  • With a quarterly dividend of $0.38 per share, translating to an annual yield of about 3.93%, investors can benefit from regular income in addition to capital gains.
  • Analysts have a consensus rating of "Hold" with several recent upgrades, indicating confidence in the company's future performance and stability in the market.

Exelon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Exelon Co. for these reasons:

  • The stock has a relatively high debt-to-equity ratio of 1.66, which may indicate financial risk, as it suggests the company relies significantly on debt to finance its operations.
  • Exelon Co. has a price-to-earnings (P/E) ratio of 15.93, which, while not excessively high, may suggest that the stock is fairly valued compared to its earnings growth potential.
  • Despite recent positive earnings, the company's revenue growth of only 2.9% year-over-year may not be sufficient to attract aggressive growth investors.
  • The stock's beta of 0.54 indicates lower volatility compared to the market, which may not appeal to investors seeking high-risk, high-reward opportunities.
  • With eleven analysts rating the stock as a "Hold," there may be limited enthusiasm for significant price increases in the near term, suggesting a cautious outlook.

EXC Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Exelon is $41.25, with a high forecast of $46.00 and a low forecast of $36.00.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exelon in the last year. There are currently 10 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" EXC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXC, but not buy additional shares or sell existing shares.

According to analysts, Exelon's stock has a predicted upside of 4.46% based on their 12-month stock forecasts.

Exelon has been rated by research analysts at Barclays, Jefferies Financial Group, Morgan Stanley, and UBS Group in the past 90 days.

Analysts like Exelon less than other "utilities" companies. The consensus rating for Exelon is Hold while the average consensus rating for "utilities" companies is Moderate Buy. Learn more on how EXC compares to other companies.


This page (NASDAQ:EXC) was last updated on 11/27/2024 by MarketBeat.com Staff
From Our Partners